Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Jake Rosvold

Jake Rosvold

ID: 1b826802-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

Large Pharmaceutical Companies Outperform Smaller Pharmaceutical and Biotechnology Companies at USPTO

Biosimilars Law Bulletin · March 25, 2026

PTAB Reforms Shift the Battleground: Why Ex Parte Reexaminations Are Gaining Ground as IPRs Fade

Biosimilars Law Bulletin · January 27, 2026

Biosimilars at the Crossroads: A $234 Billion Opportunity or a Missed Chance for Healthcare Savings?

Biosimilars Law Bulletin · February 18, 2025

Practice Areas

Health Care and Life Sciences

Jurisdictions

Washington, D.C.

Publishing Record

Publisher Since 2025

Total Articles 3

Most Recent March 25, 2026

Cite This Author

Jake Rosvold, Rothwell Figg

LexBlog Author ID:

1b826802-2619-30fb-68c4

www.lexblog.com/author/jrosvold

Contact

FirmRothwell Figg

Emailjrosvold@rothwellfigg.com

BlogBiosimilars Law Bulletin

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog